AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus
Phase 3
Completed
- Conditions
- Diabetes Mellitus, Non-Insulin-Dependent
- Interventions
- Drug: Placebo
- First Posted Date
- 2002-05-08
- Last Posted Date
- 2015-02-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 734
- Registration Number
- NCT00035984
- Locations
- 🇺🇸
Diabetes and Endocrinology Specialists, Chesterfield, Missouri, United States
🇺🇸Holston Medical Group, Kingsport, Tennessee, United States
🇺🇸University of Mississippi Medical Center, Jackson, Mississippi, United States
CAFE Comparison of Atypicals in First Episode of Psychosis
Phase 3
Completed
- Conditions
- SchizophreniaPsychotic DisordersMental HealthMental Disorders
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2013-01-04
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT00034892
- Locations
- 🇺🇸
Research Site, Dallas, Texas, United States
A Comparison of Seroquel vs. Risperidone in Schizophrenia
Phase 4
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2013-01-04
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT00034905
Iressa Expanded Access Program (EAP)
Phase 3
Completed
- Conditions
- CarcinomaNon-small-cell LungMetastasesNeoplasm
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2013-01-04
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT00034879
- Locations
- 🇺🇸
Research Site, Cheyenne, Wyoming, United States
© Copyright 2025. All Rights Reserved by MedPath